Decellularization: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 27: | Line 27: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
== Decellularization == | |||
<gallery> | |||
File:Decellularized_aortic_homograft.JPG|Decellularized aortic homograft | |||
File:Tissue_engineering_english.jpg|Tissue engineering diagram | |||
File:Decellularized-Matrix-from-Tumorigenic-Human-Mesenchymal-Stem-Cells-Promotes-Neovascularization-pone.0021888.s001.ogv|Decellularized matrix from tumorigenic human mesenchymal stem cells | |||
</gallery> | |||
Latest revision as of 04:20, 18 February 2025
Decellularization is a process used in tissue engineering and regenerative medicine to produce extracellular matrix (ECM) scaffolds that can be used to construct new organs and tissues. The process involves removing all the cells from a donor organ or tissue, leaving behind the ECM, which can then be used as a scaffold for the patient's own cells to grow on.
Process[edit]
The process of decellularization involves several steps. First, the organ or tissue is treated with a series of chemical and enzymatic solutions to remove the cells. This can include detergents, enzymes, and other chemicals that break down the cell membranes and remove the cellular material. The resulting ECM scaffold is then washed thoroughly to remove any residual cellular material and chemicals.
The decellularized scaffold is then ready to be seeded with the patient's own cells. This can be done in a variety of ways, including injecting the cells directly into the scaffold, or culturing the cells on the scaffold in a bioreactor. Over time, the cells will grow and proliferate on the scaffold, eventually forming a new organ or tissue.
Applications[edit]
Decellularization has a wide range of applications in regenerative medicine and tissue engineering. It can be used to create scaffolds for a variety of organs and tissues, including the heart, liver, lungs, and skin. These scaffolds can then be used to grow new organs and tissues for transplantation, potentially reducing the need for donor organs and the risk of organ rejection.
Decellularized scaffolds can also be used in research to study cell behavior and tissue development, and to test new drugs and therapies.
Challenges[edit]
While decellularization has great potential, there are also several challenges that need to be overcome. One of the main challenges is ensuring that the decellularized scaffold retains its original structure and function. This can be difficult, as the process of decellularization can sometimes damage the ECM and alter its properties.
Another challenge is ensuring that the patient's cells can successfully grow and proliferate on the scaffold. This can be influenced by a variety of factors, including the type of cells used, the conditions in which they are cultured, and the properties of the scaffold itself.
See also[edit]
Decellularization[edit]
-
Decellularized aortic homograft
-
Tissue engineering diagram
-
Decellularized matrix from tumorigenic human mesenchymal stem cells
